Open Access
Short Note
Issue
Parasite
Volume 26, 2019
Article Number 13
Number of page(s) 5
DOI https://doi.org/10.1051/parasite/2019013
Published online 06 March 2019
  1. Avelino MM, Amaral WN, Rodrigues IM, Rassi AR, Gomes MB, Costa TL, Castro AM. 2014. Congenital toxoplasmosis and prenatal care state programs. BMC Infectious Diseases, 14, 33. [CrossRef] [PubMed] [Google Scholar]
  2. Desmonts G, Couvreur J. 1974. Congenital toxoplasmosis. A prospective study of 378 pregnancies. New England Journal of Medicine, 290, 1110–1116. [CrossRef] [Google Scholar]
  3. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE. 2010. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Medicine, 7, 1–11, e1000351. [Google Scholar]
  4. Grover CM, Thulliez P, Remington JS, Boothroyd JD. 1990. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. Journal of Clinical Microbiology, 28(10), 2297–2301. [PubMed] [Google Scholar]
  5. Hotop A, Hlobil H, Gross U. 2012. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clinical Infectious Diseases, 54(11), 1545–1552. [CrossRef] [Google Scholar]
  6. Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. 2008. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatric Infectious Disease Journal, 27(1), 27–32. [CrossRef] [PubMed] [Google Scholar]
  7. Naessens A, Jenum PA, Pollak A, Decoster A, Lappalainen M, Villena I, Lebech M, Stray-Pedersen B, Hayde M, Pinon JM, Petersen E, Foulon W. 1999. Diagnosis of congenital toxoplasmosis in the neonatal period. A multicenter evaluation. Journal of Infectious Diseases, 181, 2018–2022. [Google Scholar]
  8. Montoya JG. 2002. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. Journal of Infectious Diseases, 185(Suppl 1), S73–S82. [CrossRef] [Google Scholar]
  9. Montoya JG. 2018. Systematic screening and treatment of toxoplasmosis during pregnancy: is the glass half full or half empty? American Journal of Obstetrics and Gynecology, 219(4), 315–319. [CrossRef] [PubMed] [Google Scholar]
  10. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. 2011. Severe congenital toxoplasmosis in the United States, clinical and serologic findings in untreated infants. Pediatric Infectious Diseases Journal, 30, 1056–1061. [CrossRef] [Google Scholar]
  11. Olariu TR, Remington JS, Montoya JG. 2014. Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatric Infectious Diseases Journal, 33(6), 566–570. [CrossRef] [Google Scholar]
  12. Peyron F, Wallon M, Kieffer F, Garweg J. 2016. Toxoplasmosis, in Infectious diseases of the fetus and newborn infant, 7th edn. Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y, Editors. Elsevier Saunders: Philadelphia, PA. p. 949–1042. [Google Scholar]
  13. Prusa AR, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. 2015. The Austrian toxoplasmosis register, 1992–2008. Clinical Infectious Diseases, 15(60), e4–e10. [CrossRef] [Google Scholar]
  14. Remington JS, McLeod R, Thuilliez P, Desmonts G. 2011. Toxoplasmosis, in Infectious diseases of the fetus and newborn infant, 7th edn. Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y, Editors. Elsevier Saunders: Philadelphia, PA. p. 918–1041. [CrossRef] [Google Scholar]
  15. Thiebaut R, Leproust S, Chene G, Gilbert R. 2007. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet, 369, 115–122. [CrossRef] [PubMed] [Google Scholar]
  16. Villena I, Ancelle T, Delmas C, Garcia P, Brézin AP, Thulliez P, Wallon M, King L, Goulet V, Toxosurv network and National Reference Centre for Toxoplasmosis. 2010. Congenital toxoplasmosis in France in 2007: First results from a national surveillance system. Eurosurveillance, 15(25), pii: 19600. [CrossRef] [Google Scholar]
  17. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. 2013. Congenital Toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clinical Infectious Diseases, 56, 1223–1231. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.